$640.78K in average volume shows that Tenaya Therapeutics Inc. (TNYA) is heading in the right direction

Tenaya Therapeutics Inc. (NASDAQ: TNYA) kicked off on May 23, 2023, at the price of $7.44, up 2.15% from the previous trading day. During the day, the shares moved up to $7.95 and dropped to $7.20 before settling in for the closing price of $7.44. Over the past 52 weeks, TNYA has traded in a range of $1.64-$7.90.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

While this was happening, its average annual earnings per share was recorded 32.70%. With a float of $61.40 million, this company’s outstanding shares have now reached $73.10 million.

Let’s look at the performance matrix of the company that is accounted for 141 employees.

Tenaya Therapeutics Inc. (TNYA) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc. is 0.30%, while institutional ownership is 55.70%. The most recent insider transaction that took place on Mar 10, was worth 17,596. In this transaction 10% Owner of this company bought 6,779 shares at a rate of $2.60, taking the stock ownership to the 11,377,053 shares. Before that another transaction happened on Mar 10, when Company’s Director bought 6,779 for $2.60, making the entire transaction worth $17,596. This insider now owns 11,377,053 shares in total.

Tenaya Therapeutics Inc. (TNYA) Latest Financial update

In the latest quarterly report, which was put into the public domain on 3/30/2023, the organization reported -$0.43 earnings per share (EPS), higher than consensus estimate (set at -$0.56) by $0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 32.70% per share during the next fiscal year.

Tenaya Therapeutics Inc. (NASDAQ: TNYA) Trading Performance Indicators

Take a look at Tenaya Therapeutics Inc.’s (TNYA) current performance indicators. Last quarter, stock had a quick ratio of 8.00.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.01 in one year’s time.

Technical Analysis of Tenaya Therapeutics Inc. (TNYA)

Tenaya Therapeutics Inc. (NASDAQ: TNYA) saw its 5-day average volume 0.72 million, a positive change from its year-to-date volume of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 72.44%. Additionally, its Average True Range was 0.69.

During the past 100 days, Tenaya Therapeutics Inc.’s (TNYA) raw stochastic average was set at 94.35%, which indicates a significant increase from 85.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.23% in the past 14 days, which was lower than the 111.39% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.44, while its 200-day Moving Average is $3.41. Nevertheless, the first resistance level for the watch stands at $7.97 in the near term. At $8.33, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.72. If the price goes on to break the first support level at $7.22, it is likely to go to the next support level at $6.83. The third support level lies at $6.47 if the price breaches the second support level.

Tenaya Therapeutics Inc. (NASDAQ: TNYA) Key Stats

The company with the Market Capitalisation of 498.56 million has total of 66,870K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -123,670 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -31,740 K.